Intravascular Imaging, Inc. (i3) is a cutting-edge company based in Boston, MA, specializing in the commercialization of novel Cardiovascular Imaging Technologies. Founded in collaboration with Massachusetts General Hospital Harvard Medical School (MGH) and the Technical University of Munich (TUMS), i3 is dedicated to advancing Biological Imaging Modalities for the early detection of Coronary Artery Disease and post-interventional therapeutic viability.
i3 believes that its innovative imaging technologies have the potential to significantly reduce the number of failed procedures and unnecessary expenses associated with in-stent restenosis, which currently amount to over $2.5 billion worldwide. Their state-of-the-art I3 NIRF-IVUS catheter combines the functionality of a 3f IVUS catheter with the ability to visualize pathophysiological information, providing clinicians with valuable insights during PCI procedures.
Generated from the website
